Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Other Accumulated Expenses (2022 - 2025)

Prokidney (PROK) has disclosed Other Accumulated Expenses for 4 consecutive years, with $667000.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 65.1% to $667000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $667000.0 through Dec 2025, down 65.1% year-over-year, with the annual reading at $667000.0 for FY2025, 65.1% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $667000.0 at Prokidney, down from $1.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $2.6 million in Q3 2024, with the low at $21000.0 in Q4 2022.
  • Average Other Accumulated Expenses over 4 years is $1.3 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses soared 7214.29% in 2023, then crashed 65.1% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $21000.0 in 2022, then skyrocketed by 7214.29% to $1.5 million in 2023, then grew by 24.41% to $1.9 million in 2024, then plummeted by 65.1% to $667000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $667000.0, $1.8 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.